Cargando…
The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma
The launch of novel chemotherapeutic agents—in particular, proteasome inhibitors and immunomodulatory drugs—dramatically changed multiple myeloma (MM) therapy, improving the response rate and prolonging progression-free survival. However, none of the anti-MM drugs are deprived of side effects. Perip...
Autores principales: | Łuczkowska, Karolina, Rutka, Magdalena, Rogińska, Dorota, Paczkowska, Edyta, Baumert, Bartłomiej, Milczarek, Sławomir, Górska, Martyna, Kulig, Piotr, Osękowska, Bogumiła, Janowski, Michał, Safranow, Krzysztof, Sommerfeld, Krzysztof, Borowiecka, Ewa, Zawodny, Piotr, Koclęga, Anna, Helbig, Grzegorz, Machaliński, Bogusław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509696/ https://www.ncbi.nlm.nih.gov/pubmed/34640602 http://dx.doi.org/10.3390/jcm10194584 |
Ejemplares similares
-
Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide
por: Milczarek, Sławomir, et al.
Publicado: (2022) -
COVID-19 during Early Phase of Autologous Stem Cell Transplantation
por: Milczarek, Sławomir, et al.
Publicado: (2021) -
Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS
por: Baumert, Bartłomiej, et al.
Publicado: (2020) -
Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients
por: Sobuś, Anna, et al.
Publicado: (2021) -
Safety of Cryopreserved Stem Cell Infusion through a Peripherally Inserted Central Venous Catheter
por: Milczarek, Sławomir, et al.
Publicado: (2023)